Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Nitropyridine >  6-Chloro-2-methyl-3-nitropyridine

6-Chloro-2-methyl-3-nitropyridine

Basic information Safety Supplier Related

6-Chloro-2-methyl-3-nitropyridine Basic information

Product Name:
6-Chloro-2-methyl-3-nitropyridine
Synonyms:
  • TIMTEC-BB SBB003832
  • TIMTEC-BB SBB003830
  • 2-CHLORO-6-METHYL-5-NITROPYRIDINE
  • 2-CHLORO-6-METHYL-3-NITROPYRIDINE
  • 2-CHLORO-5-NITRO-6-METHYLPYRIDINE
  • 2-CHLORO-5-NITRO-6-PICOLINE
  • 6-CHLORO-3-NITRO-2-METHYLPYRIDINE
  • 6-CHLORO-3-NITRO-2-PICOLINE
CAS:
22280-60-0
MF:
C6H5ClN2O2
MW:
172.57
Product Categories:
  • Pyridine
  • compounds of pyridine
  • Heterocycle-Pyridine series
  • pyridine series
  • Chlorinated heterocyclic series
  • Boronic Acid
  • Pyridines
Mol File:
22280-60-0.mol
More
Less

6-Chloro-2-methyl-3-nitropyridine Chemical Properties

Melting point:
54-58 °C
Boiling point:
200°C (rough estimate)
Density 
1.5610 (rough estimate)
refractive index 
1.5500 (estimate)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
pka
-3.26±0.10(Predicted)
form 
Powder
color 
Light beige to brown
InChI
InChI=1S/C6H5ClN2O2/c1-4-5(9(10)11)2-3-6(7)8-4/h2-3H,1H3
InChIKey
GHSRMSJVYMITDX-UHFFFAOYSA-N
SMILES
C1(C)=NC(Cl)=CC=C1[N+]([O-])=O
CAS DataBase Reference
22280-60-0(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xn,Xi
Risk Statements 
36/37/38-20/21/22-22
Safety Statements 
36/37/39-26
Hazard Note 
Harmful
HazardClass 
IRRITANT
HS Code 
29333990

MSDS

  • Language:English Provider:ACROS
More
Less

6-Chloro-2-methyl-3-nitropyridine Usage And Synthesis

Chemical Properties

Light yellow Cryst

Uses

6-Chloro-2-methyl-3-nitropyridine has been used as a reactant for the synthesis of fluorine-containing pyridinealdoxime derivatives as treatment of organophosphorus nerve-agent poisoning.

Preparation

A mixture of 2-oxo-5-nitro-6-methyl-1,2-dihydropyridine, phosphorous oxychloride, and phosphorous pentachloride was heated at 110° C for 2 hours, whereupon the reaction mixture was charged with an additional portion of phosphorous pentachloride and phosphorous oxychloride. The reaction was stirred for 1 hour and then poured into ice water. The brown solid was filtered and washed with cold water, to give 6-Chloro-2-methyl-3-nitropyridine (94%).

Synthesis

28489-45-4

22280-60-0

General procedure for the synthesis of 2-chloro-5-nitro-6-methylpyridine from 2-hydroxy-6-methyl-5-nitropyridine: 1. 2-Hydroxy-6-methyl-5-nitropyridine (500 mg, 3.24 mmol), phosphorus trichloride (POCl3, 0.5 mL) and phosphorus pentachloride (PCl5, 200 mg) were mixed and the reaction was stirred for 2 hours at 150 °C. After completion of the reaction, it was cooled to room temperature, the reaction mixture was poured into ice water and extracted with dichloromethane (DCM, 3 x 20 mL). The organic phases were combined, washed with water to pH 7, dried over anhydrous sodium sulfate (Na2SO4) and concentrated under reduced pressure. The resulting residue was dried under reduced pressure to give 6-chloro-2-methyl-3-nitropyridine (430 mg, 78% yield) as a light brown solid. 2. 3-Ethynyl-7,7-dimethyl-7,8-dihydroquinolin-5(6H)-one (199 mg, 1.00 mmol) was mixed with 6-chloro-2-methyl-3-nitropyridine (172 mg, 1.00 mmol) in the presence of PdCl2(PPh3)2 (42 mg, 0.06 mmol), P(t-Bu)3 (16 mg , 0.08 mmol) and triethylamine (TEA, 1.5 mL) in a solution of N,N-dimethylformamide (DMF, 3 mL), and the reaction was stirred at 100 °C for 3 hours. The crude product was purified by silica gel column chromatography to afford the intermediate 7,7-dimethyl-3-((6-methyl-5-nitropyridin-2-yl)ethynyl)-7,8-dihydroquinolin-5(6H)-one (80 mg, 16% yield) as a yellow solid. 3. 7,7-Dimethyl-3-((6-methyl-5-nitropyridin-2-yl)ethynyl)-7,8-dihydroquinolin-5(6H)-one (194 mg, 0.58 mmol) was dissolved in ethyl acetate (EtOAc, 10 mL) and cooled to 0°C. A concentrated aqueous hydrochloric acid solution (1 mL) of stannous chloride dihydrate (SnCl2-2H2O, 650 mg, 2.90 mmol) was slowly added. The reaction mixture was stirred at room temperature for 3 h. The reaction mixture was poured into ice water, adjusted to pH 9-10 with 15% aqueous sodium hydroxide and extracted with ethyl acetate (EtOAc, 3 × 25 mL). The organic phases were combined, dried over anhydrous sodium sulfate (Na2SO4) and concentrated under reduced pressure. The resulting residue was purified by preparative thin layer chromatography (silica gel, dichloromethane/ethanol, 40:1) to afford the target product 2-chloro-5-nitro-6-methylpyridine (34 mg, 19% yield). Product characterization: 1H NMR (DMSO-d6) δH: 1.05 (s, 6H), 2.29 (s, 3H), 2.59 (s, 2H), 3.03 (s, 2H), 5.51 (br s, 2H), 6.92 (d, 1H), 7.24 (d, 1H), 8.15 (s, 1H), 8.83 (s, 1H). LC/MS (M+H)+ = 306.

References

[1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
[2] Patent: WO2012/52451, 2012, A1. Location in patent: Page/Page column 113
[3] Patent: CN105906621, 2016, A. Location in patent: Paragraph 0021
[4] Patent: WO2005/42464, 2005, A1. Location in patent: Page/Page column 33
[5] Journal of the American Chemical Society, 1952, vol. 74, p. 3828,3830

6-Chloro-2-methyl-3-nitropyridineSupplier

LEWOO PHARMATECH (SHANGHAI) CO.,LTD Gold
Tel
15800805830
Email
miao@lewoopharma.com.cn
Shanghai Witofly Chemical Co. ,Ltd. Gold
Tel
021-50630626 18964684208
Email
sales@witofly.com
Nantong Xiaochang Pharmaceutical Trading Co., Ltd. Gold
Tel
0513-82104991 18912868361
Email
sales11@btcpharm.com
Jinan Dexinjia Bio&Tech Co., Ltd Gold
Tel
0531-82371986 15269101859
Email
3276840968@qq.com
Nanjing Hengweisheng Pharmaceutical Technology Co., Ltd Gold
Tel
19941530336
Email
3991044086@qq.com